Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Європейський Союз - латвійська - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).

Symkevi Європейський Союз - латвійська - EMA (European Medicines Agency)

symkevi

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cistiskā fibroze - other respiratory system products - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Dasselta Європейський Союз - латвійська - EMA (European Medicines Agency)

dasselta

krka, d.d., novo mesto - desloratadine - rhinitis, allergic, perennial; rhinitis, allergic, seasonal; urticaria - antihistamīna līdzekļi sistēmiskai lietošanai, - dasselta ir norādīts simptomu, kas saistīti ar:alerģisks rinīts;nātrene.

Zomarist Європейський Союз - латвійська - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - cukura diabēts - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Segluromet Європейський Союз - латвійська - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Vildagliptin / Metformin hydrochloride Accord Європейський Союз - латвійська - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - cukura diabēts, 2. tips - cukura diabēts - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).

Spironolactone Accord 25 mg apvalkotās tabletes Латвія - латвійська - Zāļu valsts aģentūra

spironolactone accord 25 mg apvalkotās tabletes

accord healthcare b.v., netherlands - spironolaktons - apvalkotā tablete - 25 mg

Spironolactone Accord 50 mg apvalkotās tabletes Латвія - латвійська - Zāļu valsts aģentūra

spironolactone accord 50 mg apvalkotās tabletes

accord healthcare b.v., netherlands - spironolaktons - apvalkotā tablete - 50 mg

Spironolactone Accord 100 mg apvalkotās tabletes Латвія - латвійська - Zāļu valsts aģentūra

spironolactone accord 100 mg apvalkotās tabletes

accord healthcare b.v., netherlands - spironolaktons - apvalkotā tablete - 100 mg